Analysed CMS (8A8:SGX) News Sources
CMS(867.HK/8A8.SG): New Drug for Renal Anaemia Desidustat Tablets Approved in China
13-03-2026
yahoo.com
CMS(867.HK/8A8.SG):Ruxolitinib Phosphate Cream (Lumirix®) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo
13-03-2026
yahoo.com
CMS(867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity
05-03-2026
yahoo.com
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
24-02-2026
yahoo.com
A Look At China Medical System Holdings (SEHK:867) Valuation After New AI Drug Partnership And Trial Approval
15-02-2026
yahoo.com
AI-Powered R&D Acceleration: Insilico Medicine and CMS announce multiple collaborations in central nervous system and autoimmune diseases
10-02-2026
yahoo.com
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China
30-01-2026
yahoo.com
CMS (867.HK/8A8.SG): Innovative Drug Oral JAK1 Inhibitor Povorcitinib Has Been Included in the List of Breakthrough Therapeutic Drugs in China
15-12-2025
yahoo.com
What is the current price of CMS (8A8:SGX)?
The current price of CMS (8A8:SGX) is $2.25.
CMS (8A8:SGX) absolute price change since previous trading day?
The absolute price change of CMS (8A8:SGX) since the previous trading day is $-0.15.
CMS (8A8:SGX) percentage price change since previous trading day?
The percentage price change of CMS (8A8:SGX) since the previous trading day is -6.25%.
What is the most recent average sentiment score for CMS (8A8:SGX)?
The most recent average sentiment score for CMS (8A8:SGX) is 70 out of 100.
What is the most recent average sentiment for CMS (8A8:SGX)?
The most recent sentiment for CMS (8A8:SGX) is .
SEC-8K** Filing Unavailable For CMS (8A8:SGX)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.